Session 6
Clinical applications: Radio-chemo-immunotherapy

Programme

• 15:45 – 16:05 15 Min. 5 Min.

  • Invited Talk
  • IT-06

  Hyperthermia as an adjuncive treatment in the treatment of tumors: review of studies

  • Prof. Giammaria Fiorentini (Pesaro / IT)
• 16:05 – 16:17 9 Min. 3 Min.

  • Oral Presentation
  • OP-26

  Feasibility and tolerance of deep hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: First spanish experience

  • Dr. Laura Ferrera-Alayón (Las Palmas de Gran Canaria / ES)

   Hyperthermia clinical applications: radio-chemo-immunotherapy
• 16:17 – 16:29 9 Min. 3 Min.

  • Oral Presentation
  • OP-27

  Hyperthermia enhances spatially-fractionated radiation and immunotherapy in pre-clinical tumor models

  • Prof. Robert Griffin (Little Rock / US)

   Hyperthermia clinical applications: radio-chemo-immunotherapy
• 16:29 – 16:41 9 Min. 3 Min.

  • Oral Presentation
  • OP-28

  Phase I study of THE001 (DPPG2-TSL-DOX) combined with regional hyperthermia in patients with locally advanced or metastatic soft tissue sarcoma

  • Prof. Dr. Lars Lindner (Munich / DE)

   Hyperthermia clinical applications: radio-chemo-immunotherapy
• 16:41 – 16:43 2 Min. 0 Min.

  • Flash Presentation
  • FP-25

  Enhancing quality of life in bladder cancer patients: leveraging hyperthermia and chemotherapy

  • Dr. Sopio Badzgaradze (Kutaisi / GE)

   Hyperthermia clinical applications: radio-chemo-immunotherapy
• 16:43 – 16:45 2 Min. 0 Min.

  • Flash Presentation
  • FP-26

  Numerical study of hyperthermia application for head and neck tumour with varying complexity of the human model

  • Dr. Marco Di Cristofano (Rome / IT)

   Q&A: thermometry, treatment planning, image guide
• 16:45 – 16:47 2 Min. 0 Min.

  • Flash Presentation
  • FP-27

  Synergistic nanoparticle-mediated therapies: Enhancing antitumor efficacy through immune modulation and targeted hyperthermia

  • Dr. Deepika Sharma (Mohali / IN)

   Basic research in Hyperthermia: biological-immune response
• 16:47 – 16:49 2 Min. 0 Min.

  • Flash Presentation
  • FP-28

  Effect of biocompatible polyacrylic acid-coated iron oxide-based magnetic fluid in inducing programmed cell death in breast cancer cells MCF-7 subsequent to magnetic fluid hyperthermia

  • Dr. Neeraj Jain (Changa / IN)

   Basic research in Hyperthermia: biological-immune response
• 16:49 – 16:51 2 Min. 0 Min.

  • Flash Presentation
  • FP-29

  Biological modeling shows thermal enhancement of radiation dose in a pediatric sarcoma patient treated with proton beam therapy and regional deep hyperthermia

  • Mattia De Lazzari (Göteborg / SE)

   Hyperthermia clinical applications: radio-chemo-immunotherapy